Canalicular stenosis associated with dupilumab treatment for atopic dermatitis

Eur J Dermatol. 2021 Dec 1;31(6):843-844. doi: 10.1684/ejd.2021.4180.

Authors

Lotte Loret¹, Virginie Ninclaus¹, Amélie Dendooven², Hilde Lapeere³, Elke O Kreps⁴

Affiliations

¹ Department of Ophthalmology, Ghent University Hospital, Ghent, Belgium.
² Department of Pathology, Ghent University Hospital, Ghent, Belgium, Faculty of Medical Sciences, Ghent University, Ghent, Belgium.
³ Faculty of Medical Sciences, Ghent University, Ghent, Belgium, Department of Dermatology, Ghent University Hospital, Ghent, Belgium.
⁴ Department of Ophthalmology, Ghent University Hospital, Ghent, Belgium, Faculty of Medical Sciences, Ghent University, Ghent, Belgium.

PMID: 34933837
DOI: 10.1684/ejd.2021.4180

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Antibodies, Monoclonal, Humanized / adverse effects*
Conjunctivitis, Allergic / chemically induced
Conjunctivitis, Allergic / pathology
Constriction, Pathologic / chemically induced*
Dermatitis, Atopic / drug therapy*
Dermatologic Agents / adverse effects*
Humans
Interleukin-4 Receptor alpha Subunit / antagonists & inhibitors*
Lacrimal Apparatus / pathology*
Male
Middle Aged
Pruritus / chemically induced
Pruritus / pathology

Substances

Antibodies, Monoclonal, Humanized
Dermatologic Agents
Interleukin-4 Receptor alpha Subunit
dupilumab